Aquatic Capital Management LLC Decreases Stake in Agilent Technologies, Inc. $A

Aquatic Capital Management LLC reduced its position in Agilent Technologies, Inc. (NYSE:A) by 43.6% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 53,601 shares of the medical research company’s stock after selling 41,359 shares during the period. Aquatic Capital Management LLC’s holdings in Agilent Technologies were worth $6,880,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in A. Norges Bank bought a new stake in shares of Agilent Technologies in the second quarter valued at approximately $395,088,000. AQR Capital Management LLC boosted its holdings in Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after buying an additional 1,652,244 shares during the period. Ameriprise Financial Inc. boosted its holdings in Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after buying an additional 1,340,161 shares during the period. Troy Asset Management Ltd grew its stake in Agilent Technologies by 74.3% in the 2nd quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock valued at $282,967,000 after buying an additional 1,021,865 shares in the last quarter. Finally, Ilex Capital Partners UK LLP purchased a new position in Agilent Technologies in the 2nd quarter valued at approximately $96,684,000.

Wall Street Analysts Forecast Growth

A has been the topic of several recent research reports. Wells Fargo & Company dropped their target price on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. Morgan Stanley decreased their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. JPMorgan Chase & Co. increased their price objective on Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. TD Cowen cut their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Finally, Robert W. Baird lifted their target price on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a report on Tuesday, November 25th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $161.20.

Agilent Technologies Price Performance

NYSE:A opened at $111.60 on Monday. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The stock has a fifty day moving average of $130.34 and a 200 day moving average of $135.95. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The firm has a market capitalization of $31.54 billion, a price-to-earnings ratio of 24.64, a P/E/G ratio of 2.35 and a beta of 1.31.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). The business had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business’s revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.52%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.